|
1
|
Wang X and Fang L: Advances in circular
RNAs and their roles in breast cancer. J Exp Clin Cancer Res.
37:2062018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Key TJ, Verkasalo PK and Banks E:
Epidemiology of breast cancer. Lancet Oncol. 2:133–140. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Malvezzi M, Carioli G, Bertuccio P, Rosso
T, Boffetta P, Levi F, La Vecchia C and Negri E: European cancer
mortality predictions for the year 2016 with focus on leukemias.
Ann Oncol. 27:725–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brufsky AM: Long-term management of
patients with hormone receptor-positive metastatic breast cancer:
Concepts for sequential and combination endocrine-based therapies.
Cancer Treat Rev. 59:22–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Majeed W, Aslam B, Javed I, Khaliq T,
Muhammad F, Ali A and Raza A: Breast cancer: Major risk factors and
recent developments in treatment. Asian Pac J Cancer Prev.
15:3353–3358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jafari SH, Saadatpour Z, Salmaninejad A,
Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H and Kianmehr
M: Breast cancer diagnosis: Imaging techniques and biochemical
markers. J Cell Physiol. 233:5200–5213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R
and Li H: The emerging functions and roles of circular RNAs in
cancer. Cancer Lett. 414:301–309. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han YN, Xia SQ, Zhang YY, Zheng JH and Li
W: Circular RNAs: A novel type of biomarker and genetic tools in
cancer. Oncotarget. 8:64551–64563. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Chen Z, Hu G and Jiang Y: Roles of
circular RNA in breast cancer: Present and future. Am J Transl Res.
11:3945–3954. 2019.PubMed/NCBI
|
|
11
|
Zhou SY, Chen W, Yang SJ, Xu ZH, Hu JH,
Zhang HD, Zhong SL and Tang JH: The emerging role of circular RNAs
in breast cancer. Biosci Rep. 39:BSR201906212019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ng WL, MohdMohidin TB and Shukla K:
Functional role of circular RNAs in cancer development and
progression. RNA Biol. 15:995–1005. 2018.PubMed/NCBI
|
|
13
|
Lukiw WJ: Circular RNA (circRNA) in
Alzheimer's disease (AD). Front Genet. 4:3072013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou J, Zhang WW, Peng F, Sun JY, He ZY
and Wu SG: Downregulation of hsa_circ_0011946 suppresses the
migration and invasion of the breast cancer cell line MCF-7 by
targeting RFC3. Cancer Manag Res. 10:535–544. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lü L, Sun J, Shi P, Kong W, Xu K, He B,
Zhang S and Wang J: Identification of circular RNAs as a promising
new class of diagnostic biomarkers for human breast cancer.
Oncotarget. 8:44096–44107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Ma F, Wu L, Zhang X, Tian J, Li J,
Cao J, Ma Y, Zhang L and Wang L: Identification of Hsa_circ_0104824
as a potential biomarkers for breast cancer. Technol Cancer Res
Treat. 19:15330338209607452020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bian Q: Circular RNA PVT1 promotes the
invasion and epithelial-mesenchymal transition of breast cancer
cells through serving as a competing endogenous RNA for miR-204-5p.
Onco Targets Ther. 12:11817–11826. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi Z, Li Y, Wu Y, Zeng B, Li H, Ren G and
Wang X: Circular RNA 0001073 attenuates malignant biological
behaviours in breast cancer cell and is delivered by nanoparticles
to inhibit mice tumour growth. Onco Targets Ther. 13:6157–6169.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang YY, Zhao P, Zou TN, Duan JJ, Zhi R,
Yang SY, Yang DC and Wang XL: Circular RNA hsa_circ_0001982
promotes breast cancer cell carcinogenesis through decreasing
miR-143. DNA Cell Biol. 36:901–908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin WB, Yan MG, Fang X, Guo JJ, Xiong W
and Zhang RP: Circulating circular RNA hsa_circ_0001785 acts as a
diagnostic biomarker for breast cancer detection. Clin Chim Acta.
487:363–368. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Jiang Z, Chen C, Hu Q, Fu Z, Chen J,
Wang Z, Wang Q, Li A, Marks JR, et al: CircIRAK3 sponges miR-3607
to facilitate breast cancer metastasis. Cancer Lett. 430:179–192.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayes DF, Allred C, Anderson BO, et al:
Breast. American Joint Committee on Cancer (AJCC) Cancer Staging
Manual. 7th edition. Edge SB, Byrd DR and Compton CC: Springer; New
York, NY: pp. 347–376. 2009
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chekhun VF, Lukianova NY, Chekhun SV,
Bezdieniezhnykh NO, Zadvorniy TV, Borikun TV, Polishchuk LZ and
Klyusov OМ: Association of CD44+CD24−/low
with markers of aggressiveness and plasticity of cell lines and
tumors of patients with breast cancer. Exp Oncol. 39:203–211. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang T, Zhu Q, Li X, Zhu G, Deng S, Wang
Y, Ni L, Chen X, Zhang Y, Xia T, et al: Protease Nexin I is a
feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer
cells metastasis and stemness. Cell Death Dis. 10:6492019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Croker AK, Goodale D, Chu J, Postenka C,
Hedley BD, Hess DA and Allan AL: High aldehyde dehydrogenase and
expression of cancer stem cell markers selects for breast cancer
cells with enhanced malignant and metastatic ability. J Cell Mol
Med. 13:2236–2252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan
L, Andrews R, Zhong W, Zhang X, Song E, et al: Circular RNA
hsa_circ_001783 regulates breast cancer progression via sponging
miR-200c-3p. Cell Death Dis. 10:552019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tasharrofi B and Ghafouri-Fard S: Long
non-coding RNAs as regulators of the mitogen-activated protein
kinase (MAPK) pathway in cancer. Klin Onkol. 31:95–102. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roversi FM, Olalla Saad ST and
Machado-Neto JA: Serine peptidase inhibitor Kunitz type 2 (SPINT2)
in cancer development and progression. Biomed Pharmacother.
101:278–286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nair AA, Niu N, Tang X, Thompson KJ, Wang
L, Kocher JP, Subramanian S and Kalari KR: Circular RNAs and their
associations with breast cancer subtypes. Oncotarget.
7:80967–80979. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Li J, Du C, Zhang L, Zhang Y,
Zhang J and Wang L: Upregulated circular RNA circ-UBE2D2 predicts
poor prognosis and promotes breast cancer progression by sponging
miR-1236 and miR-1287. Transl Oncol. 12:1305–1313. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martinez AM and Cavalli G: The role of
polycomb group proteins in cell cycle regulation during
development. Cell Cycle. 5:1189–1197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Margueron R and Reinberg D: The polycomb
complex PRC2 and its mark in life. Nature. 469:343–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X, Hu B, Shen H, Zhou H, Xue X, Chen
Y, Chen S, Han Y, Yuan B, Zhao H, et al: Clinical and prognostic
relevance of EZH2 in breast cancer: A meta-analysis. Biomed
Pharmacother. 75:218–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boostani F, Dolatkhah R, Fakhrjou A,
Farassati F and Sanaat Z: Association of clinicopathologic
characteristics and outcomes with EZH2 expression in patients with
breast cancer in East Azerbaijan, Iran. Onco Targets Ther.
11:449–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen L, Cui J, Liang S, Pang Y and Liu P:
Update of research on the role of EZH2 in cancer progression. Onco
Targets Ther. 6:321–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pourakbar S, Pluard TJ, Accurso AD and
Farassati F: Ezh2. A novel target in detection and therapy of
breast cancer. Onco Targets Ther. 10:2685–2687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xue J, Liu Y, Luo F, Lu X, Xu H, Liu X, Lu
L, Yang Q, Chen C, Fan W and Liu Q: Circ100284, via miR-217
regulation of EZH2, is involved in the arsenite-accelerated cell
cycle of human keratinocytes in carcinogenesis. Biochim Biophys
Acta Mol Basis Dis. 1863:753–763. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Beca F, Kensler K, Glass B, Schnitt SJ,
Tamimi RM and Beck AH: EZH2 protein expression in normal breast
epithelium and risk of breast cancer: Results from the Nurses'
health studies. Breast Cancer Res. 19:212017. View Article : Google Scholar : PubMed/NCBI
|
